🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the statistical non inferiority of the combination of latano...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-07
Trial ID
NCT00140049
The study investigated the 24-hour efficacy and ocular surface health with ...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02802137
Treatments Being Tested
After implantation of an Ahmed glaucoma valve in patients with glaucoma, hy...
Status
Unknown
Location
Credit Valley Eye Care
Start Date
2012-02
Trial ID
NCT01535768
Treatments Being Tested
To prove the non-inferiority of the fixed timolol-dorzolamide combination (...
Status
Completed
Location
Seoul St. Mary's hospital
Start Date
2011-03
Trial ID
NCT01175902
Treatments Being Tested
Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT03966560
Investigation of the effect on the pupillary constriction by latanoprost, d...
Status
Completed
Location
Glostrup University Hospital
Start Date
2014-05
Trial ID
NCT02522039
Treatments Being Tested
Glaucoma is a progressive disease resulting in blindness. Determining the o...
Status
Terminated
Location
Bascom Palmer Eye Institute - University of Miami
Start Date
2015-09
Trial ID
NCT02390284
Treatments Being Tested
The primary objective of this crossover trial is to compare the 3-month mea...
Status
Completed
Location
Glaucoma Unit, A University Dept of Ophthalmology
Start Date
2006-09
Trial ID
NCT00397241
IOP effect of half-dose latanoprost dorzolamide-timolol will be compared to...
Status
Terminated
Location
CT Glaucoma Associates
Start Date
2024-04-22
Trial ID
NCT06369077
Treatments Being Tested
This study is designed to identify physiological, pharmacological and patho...
Status
Completed
Location
University of Nebraska Medical Center, Department of Ophthalmolgy and Visual Sciences
Start Date
2006-03-13
Trial ID
NCT00572936
Treatments Being Tested